Literature DB >> 24959437

A Prospective Study of Variability in Glycemic Control during Different Phases of the Menstrual Cycle in Type 2 Diabetic Women Using High Sensitivity C - Reactive Protein.

T S Gugapriya1, S Karthick2, B Nagarjuna3.   

Abstract

INTRODUCTION: Diabetes mellitus (DM) is one of the metabolic syndromes prevalent worldwide, with more concentration in the Asian region. Many studies have been conducted in order to understand the complex pathogenesis of this disease. Yet, there exists a lacuna in our knowledge about DM. This study aims at establishing the reason for glycemic variation in menstruating Type-2 diabetic women by estimation of C-reactive protein, an inflammatory marker that exhibits significant association with changes in blood glucose levels.
METHODOLOGY: A prospective study was undertaken in Type-2 diabetic women of reproductive age group to assess the variability of glycemic control during different phases of menstrual cycle using high sensitivity C reactive protein (hs-CRP) as the biomarker. Fifty women were enrolled after satisfying a set of inclusion and exclusion criteria. The fasting blood glucose, hs-CRP concentration and endogenous female hormones were assayed in follicular and luteal phases of the cycle. The observed parameters were analyzed statistically for significant correlation. Observation and Result: The result showed that hs-CRP level significantly correlates with increasing levels of fasting blood glucose level in both the phases of menstrual cycle in Type-2 diabetic women. The significance is statistically stronger during luteal phase of the cycle (r = 0.807; p<0.05). The correlation observed between hs-CRP and Estrodiol in follicular phase (r = -0.311; p < 0.05) was not statistically significant. The hs-CRP level increased significantly with progesterone level during luteal phase (r = 0.826; p <0.05).
CONCLUSION: This study concludes that Type-2 diabetic women of reproductive age group encounter a period of poor glycemic control during luteal phase, as shown by statistically high hs-CRP level mediated by endogenous progesterone hormone. Therefore, this study advocates careful monitoring, life style adjustments and drug regime to reduce the fluctuation in glycemic level experienced by Type-2 diabetic premenopausal women in the luteal phase.

Entities:  

Keywords:  Biomarker; Fasting blood glucose level; Glycemic control; Luteal phase; Menstrual cycle; Type2 diabetic female; hs-crp

Year:  2014        PMID: 24959437      PMCID: PMC4064864          DOI: 10.7860/JCDR/2014/8118.4240

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  39 in total

1.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Wolfgang Rathmann; Guido Giani
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

2.  Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women.

Authors:  Claudine A Blum; Beat Müller; Peter Huber; Marius Kraenzlin; Christian Schindler; Christian De Geyter; Ulrich Keller; Jardena J Puder
Journal:  J Clin Endocrinol Metab       Date:  2005-03-29       Impact factor: 5.958

3.  Prevalence of inflammatory markers (high-sensitivity C-reactive protein, nuclear factor-κB, and adiponectin) in Indian patients with type 2 diabetes mellitus with and without macrovascular complications.

Authors:  Durga Prasanna Misra; Sidhartha Das; Pratima Kumari Sahu
Journal:  Metab Syndr Relat Disord       Date:  2012-02-08       Impact factor: 1.894

4.  C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: the Minoh Study.

Authors:  Noriyuki Nakanishi; Tsunehito Shiraishi; Mariko Wada
Journal:  Circ J       Date:  2005-04       Impact factor: 2.993

Review 5.  Inflammation, stress, and diabetes.

Authors:  Kathryn E Wellen; Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

6.  High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes.

Authors:  Yuji Tajiri; Kazuo Mimura; Fumio Umeda
Journal:  Obes Res       Date:  2005-10

7.  Serum C-reactive protein level and prediabetes in two Asian populations.

Authors:  C Sabanayagam; A Shankar; S C Lim; J Lee; E S Tai; T Y Wong
Journal:  Diabetologia       Date:  2011-01-26       Impact factor: 10.122

8.  Insulin sensitivity during the menstrual cycle.

Authors:  H Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  1984-08       Impact factor: 5.958

9.  Sex difference in the association of metabolic syndrome with high sensitivity C-reactive protein in a Taiwanese population.

Authors:  Ming-May Lai; Chia-Ing Li; Sharon L R Kardia; Chiu-Shong Liu; Wen-Yuan Lin; Yih-Dar Lee; Pei-Chia Chang; Cheng-Chieh Lin; Tsai-Chung Li
Journal:  BMC Public Health       Date:  2010-07-21       Impact factor: 3.295

10.  The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford
Journal:  Atherosclerosis       Date:  2003-06       Impact factor: 5.162

View more
  1 in total

1.  Menstrual cycle rhythmicity: metabolic patterns in healthy women.

Authors:  C F Draper; K Duisters; B Weger; A Chakrabarti; A C Harms; L Brennan; T Hankemeier; L Goulet; T Konz; F P Martin; S Moco; J van der Greef
Journal:  Sci Rep       Date:  2018-10-01       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.